CRP and myeloid sarcoma: Therefore, the importance of weight loss, accompanied by reductions in percentage body fat, requires further investigation in this population to evaluate the usefulness of CRP as a prognostic marker of inflammation and disease state in a subgroup of overweight/obese patients with HF, DM and/or MS.